top of page

Publications

Review Article

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

2011

Authors:

Butterfield L.H., Palucka A.K., Britten C.M., Dhodapkar M.V., Hakansson L., Janetzki S., Kawakami, Y., Kleen T.O., Lee P.P., Maccalli C., Maecker H.T., Maino V.C., Maio M., Malyguine A., Masucci G., Pawelec G., Potter D.M., Rivoltini L.M., Salazar L.G., Schendel D.G., Slingluff C.L., Song W., Stroncek D.F., Tahara H., Thurin M., Trinchieri G., van Der Burg S.H., Whiteside T.L., Wigginton J.M., Marincola F.M., Fox B.A., Disis M.L. 

Journal:

Clinical Cancer Research

Volume:

17(10)

Page:

3064-76

Original Article

TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy

Tumor Microenvironment

2011

Authors:

Lu H., Yang Y., Gad E., Inatsuka C., Wenner C. A., Disis M. L., Standish L. J.

Journal:

Clinical Cancer Research

Volume:

17(21)

Page:

6742-53

Review Article

The ultimate in cancer chemoprevention: cancer vaccines

Cancer Vaccines

2010

Authors:

Disis ML.

Journal:

Cancer Prevention Research

Volume:

3(4)

Page:

406=9

Original Article

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

Cancer Vaccines

2010

Authors:

Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, and Knutson KL

Journal:

Cancer Immunology, Immunotherapy

Volume:

59(1)

Page:

161-71

Original Article

Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment

Tumor Microenvironment

2010

Authors:

Kievit F. M., Florczyk S. J., Leung, M. C., Veiseh, O., Park, J. O., Disis, M. L., Zhang, M.

Journal:

Biomaterials

Volume:

31(22)

Page:

5903-10

Review Article

Immune Regulation of Cancer

General Immune Research

2010

Authors:

Disis, M.L.

Journal:

Journal of Clinical Oncology

Volume:

28(29)

Page:

4531-9

Review Article

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force

2010

Authors:

Butterfield L. H., Disis M. L., Khleif S. N., Balwit J. M., Marincola F. M.

Journal:

Journal of Translational Medicine

Volume:

8

Page:

130

Original Article

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

Cancer Vaccines

2010

Authors:

Olson B. M., Frye T. P., Johnson L. E., Fong L., Knutson K. L., Disis M. L., McNeel D. G.

Journal:

Cancer Immunology Immunotherapy

Volume:

59(6)

Page:

943-53

Review Article

Progress in the development of a therapeutic vaccine for breast cancer

Cancer Vaccines

2010

Authors:

Coveler, A.L. Bates, N.E., Disis, M.L.

Journal:

Breast Cancer (Dove Press)

Volume:

2

Page:

25-36

Original Article

Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade

Tumor Microenvironment

2010

Authors:

Lu H., Wagner W. M., Gad E., Yang Y., Duan H., Amon L. M., Van Denend N., Larson E. R., Chang A., Tufvesson H., Disis M. L.

Journal:

The Journal of Immunology

Volume:

184(9)

Page:

5360-7

bottom of page